Article
Developing therapeutic ‘arrows’ with the precision of William Tell
1 Jun 2015
Abstract excerpt
PURPOSE OF REVIEW: A core mission for modern medicine is the development of precision therapeutics. Cancer therapies have been at the leading edge of this effort, while nephrology has lagged on the path to precision medicine. Breaking the stalemate, recent work revealed CD80 (B7-1) as a candidate for targeted therapy in the treatment of resistant nephrotic syndrome. This review aims to summarize the current state...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
